SEC filing details

Document Details

Form
Filing Date
02.13.2024
Document Date
12.31.2023
Form Description
Annual filing director officer or owner of more than ten percent
Filing Group
3,4,5
Company
BridgeBio Pharma
Issuer
BRIDGEBIO PHARMA, INC.
Filer
VALANTINE HANNAH